PRODUCT DETAILS Date 08 Dec 2020 Category products ABOUT THIS PRODUCT 0 For treatment of infections due to susceptible organisms. Such infections include: Lower respiratory tract infections (e.g., bronchitis, pneumonia) Upper respiratory tract infections (e.g. pharyngitis, sinusitis, tonsillitis) Acute otitis media in children Skin and soft tissue infections (e.g., folliculitis, cellulitis, erysipelas, impetigo, abscesses) Disseminated or localized mycobacterial infections due to MAC. To eradicate Helicobacter pylori in treatment regimens for peptic ulcer disease. To prevent disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection. As an alternative treatment to penicillins for prophylaxis of endocarditis. Available as: Tablets 250MG 500MG Granules 125MG/5ML 250MG/5ML Drops 125MG/5ML